| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiac Surgical Procedures | 48 | 2025 | 249 | 17.230 |
Why?
|
| Acute Kidney Injury | 17 | 2025 | 132 | 7.600 |
Why?
|
| Thoracic Surgery | 9 | 2024 | 68 | 2.870 |
Why?
|
| Postoperative Complications | 20 | 2024 | 1202 | 2.490 |
Why?
|
| Coronavirus Infections | 6 | 2020 | 192 | 2.470 |
Why?
|
| Pneumonia, Viral | 6 | 2020 | 205 | 2.450 |
Why?
|
| Anemia | 5 | 2024 | 119 | 2.370 |
Why?
|
| Perioperative Care | 9 | 2024 | 76 | 2.360 |
Why?
|
| Coronary Artery Bypass | 12 | 2024 | 274 | 1.940 |
Why?
|
| Practice Guidelines as Topic | 5 | 2024 | 705 | 1.750 |
Why?
|
| Betacoronavirus | 6 | 2020 | 166 | 1.670 |
Why?
|
| Humans | 87 | 2025 | 59360 | 1.580 |
Why?
|
| Pandemics | 9 | 2021 | 615 | 1.550 |
Why?
|
| Operating Rooms | 3 | 2020 | 55 | 1.470 |
Why?
|
| Surgeons | 5 | 2024 | 161 | 1.350 |
Why?
|
| Consensus | 9 | 2024 | 193 | 1.340 |
Why?
|
| Heart Valve Prosthesis | 2 | 2023 | 92 | 1.330 |
Why?
|
| Medicare | 4 | 2022 | 598 | 1.230 |
Why?
|
| Biomarkers | 7 | 2022 | 1306 | 1.140 |
Why?
|
| Extracorporeal Membrane Oxygenation | 2 | 2018 | 52 | 1.090 |
Why?
|
| Heart Diseases | 3 | 2020 | 206 | 1.080 |
Why?
|
| Coronary Artery Disease | 3 | 2024 | 273 | 1.060 |
Why?
|
| Patient Care Team | 3 | 2020 | 326 | 1.050 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2025 | 114 | 1.050 |
Why?
|
| Delivery of Health Care | 2 | 2020 | 408 | 1.020 |
Why?
|
| Health Expenditures | 2 | 2017 | 113 | 1.010 |
Why?
|
| Complement Inactivating Agents | 1 | 2025 | 13 | 0.980 |
Why?
|
| Fluid Therapy | 2 | 2022 | 47 | 0.920 |
Why?
|
| Goals | 2 | 2022 | 88 | 0.890 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2024 | 98 | 0.880 |
Why?
|
| Rheumatic Heart Disease | 3 | 2021 | 7 | 0.880 |
Why?
|
| Infectious Disease Transmission, Professional-to-Patient | 2 | 2020 | 5 | 0.860 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 2 | 2020 | 14 | 0.850 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2025 | 219 | 0.840 |
Why?
|
| Chest Tubes | 1 | 2023 | 16 | 0.830 |
Why?
|
| Delirium | 2 | 2020 | 54 | 0.830 |
Why?
|
| Health Resources | 3 | 2020 | 87 | 0.820 |
Why?
|
| Infection Control | 2 | 2020 | 94 | 0.790 |
Why?
|
| Cross Infection | 2 | 2020 | 149 | 0.760 |
Why?
|
| Benchmarking | 2 | 2020 | 135 | 0.750 |
Why?
|
| Delivery of Health Care, Integrated | 2 | 2020 | 112 | 0.740 |
Why?
|
| Aortic Valve Stenosis | 1 | 2023 | 170 | 0.700 |
Why?
|
| Recovery Room | 1 | 2020 | 3 | 0.690 |
Why?
|
| Early Diagnosis | 1 | 2020 | 92 | 0.690 |
Why?
|
| Glomerular Filtration Rate | 1 | 2020 | 101 | 0.680 |
Why?
|
| Reimbursement Mechanisms | 2 | 2017 | 40 | 0.680 |
Why?
|
| Prospective Payment System | 2 | 2017 | 8 | 0.680 |
Why?
|
| Pressure Ulcer | 1 | 2020 | 34 | 0.660 |
Why?
|
| Transfusion Reaction | 1 | 2019 | 44 | 0.660 |
Why?
|
| Triage | 5 | 2022 | 109 | 0.650 |
Why?
|
| Intraoperative Care | 2 | 2020 | 36 | 0.650 |
Why?
|
| Bioprosthesis | 2 | 2023 | 39 | 0.640 |
Why?
|
| Length of Stay | 6 | 2024 | 775 | 0.630 |
Why?
|
| Inservice Training | 2 | 2017 | 81 | 0.630 |
Why?
|
| Nutritional Support | 1 | 2019 | 12 | 0.630 |
Why?
|
| Awareness | 2 | 2022 | 74 | 0.610 |
Why?
|
| Disease Management | 1 | 2020 | 221 | 0.610 |
Why?
|
| Scabies | 1 | 2018 | 4 | 0.610 |
Why?
|
| Risk Assessment | 6 | 2020 | 1921 | 0.590 |
Why?
|
| Purchasing, Hospital | 1 | 2017 | 1 | 0.580 |
Why?
|
| Equipment and Supplies, Hospital | 1 | 2017 | 4 | 0.580 |
Why?
|
| Interdisciplinary Communication | 2 | 2020 | 103 | 0.570 |
Why?
|
| Analgesics, Opioid | 2 | 2022 | 483 | 0.570 |
Why?
|
| Risk Factors | 14 | 2024 | 4984 | 0.570 |
Why?
|
| Quality Control | 1 | 2017 | 71 | 0.570 |
Why?
|
| Clinical Competence | 3 | 2020 | 683 | 0.560 |
Why?
|
| Children's Health Insurance Program | 1 | 2017 | 3 | 0.560 |
Why?
|
| Work Engagement | 1 | 2017 | 14 | 0.560 |
Why?
|
| Societies, Medical | 4 | 2024 | 338 | 0.560 |
Why?
|
| Patient Care Bundles | 1 | 2017 | 11 | 0.550 |
Why?
|
| Value-Based Purchasing | 1 | 2017 | 8 | 0.550 |
Why?
|
| Patient-Centered Care | 1 | 2020 | 246 | 0.550 |
Why?
|
| Stroke | 3 | 2015 | 1127 | 0.540 |
Why?
|
| Treatment Outcome | 11 | 2025 | 5284 | 0.540 |
Why?
|
| Hospital Costs | 1 | 2017 | 119 | 0.540 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2017 | 43 | 0.530 |
Why?
|
| Heart Failure | 1 | 2024 | 853 | 0.530 |
Why?
|
| Ultrasonography | 2 | 2016 | 459 | 0.520 |
Why?
|
| Heart Valves | 1 | 2016 | 23 | 0.520 |
Why?
|
| Time Factors | 9 | 2024 | 3617 | 0.500 |
Why?
|
| Pulmonary Embolism | 1 | 2018 | 170 | 0.500 |
Why?
|
| Heart-Assist Devices | 1 | 2017 | 129 | 0.490 |
Why?
|
| Respiratory Insufficiency | 1 | 2017 | 148 | 0.490 |
Why?
|
| Critical Care | 3 | 2020 | 397 | 0.480 |
Why?
|
| Postoperative Period | 3 | 2021 | 127 | 0.480 |
Why?
|
| Leadership | 1 | 2017 | 194 | 0.470 |
Why?
|
| Nurses | 1 | 2016 | 102 | 0.470 |
Why?
|
| Opioid-Related Disorders | 1 | 2022 | 456 | 0.470 |
Why?
|
| Blood Transfusion | 4 | 2024 | 150 | 0.470 |
Why?
|
| Coronary Care Units | 1 | 2013 | 4 | 0.440 |
Why?
|
| Hospital Information Systems | 1 | 2013 | 11 | 0.440 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2013 | 60 | 0.430 |
Why?
|
| Tissue and Organ Harvesting | 2 | 2010 | 24 | 0.410 |
Why?
|
| Recovery of Function | 4 | 2024 | 270 | 0.410 |
Why?
|
| Retrospective Studies | 7 | 2024 | 6071 | 0.410 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2025 | 677 | 0.400 |
Why?
|
| Mass Screening | 2 | 2021 | 645 | 0.390 |
Why?
|
| Foramen Ovale, Patent | 1 | 2012 | 13 | 0.390 |
Why?
|
| Mammary Arteries | 2 | 2022 | 10 | 0.380 |
Why?
|
| Prospective Studies | 7 | 2024 | 3067 | 0.380 |
Why?
|
| Physicians | 1 | 2017 | 435 | 0.380 |
Why?
|
| Embolism | 1 | 2012 | 39 | 0.380 |
Why?
|
| Surgical Wound Infection | 2 | 2024 | 110 | 0.370 |
Why?
|
| United States | 10 | 2023 | 7390 | 0.360 |
Why?
|
| Heart | 5 | 2021 | 274 | 0.350 |
Why?
|
| Saphenous Vein | 1 | 2010 | 47 | 0.350 |
Why?
|
| Mitral Valve | 2 | 2023 | 105 | 0.340 |
Why?
|
| Endoscopy | 1 | 2010 | 98 | 0.330 |
Why?
|
| Hemodynamics | 3 | 2024 | 230 | 0.330 |
Why?
|
| Male | 22 | 2024 | 27739 | 0.310 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2013 | 724 | 0.300 |
Why?
|
| Nitric Oxide | 4 | 1996 | 146 | 0.300 |
Why?
|
| Advisory Committees | 2 | 2020 | 108 | 0.300 |
Why?
|
| ROC Curve | 2 | 2020 | 266 | 0.290 |
Why?
|
| Program Development | 3 | 2020 | 203 | 0.290 |
Why?
|
| Multicenter Studies as Topic | 2 | 2025 | 130 | 0.290 |
Why?
|
| Blood Loss, Surgical | 2 | 2024 | 57 | 0.280 |
Why?
|
| Intensive Care Units | 3 | 2020 | 423 | 0.280 |
Why?
|
| Aged | 11 | 2024 | 13416 | 0.280 |
Why?
|
| Cardiopulmonary Bypass | 2 | 2025 | 53 | 0.270 |
Why?
|
| Myocardial Reperfusion Injury | 3 | 2000 | 26 | 0.270 |
Why?
|
| Mitral Valve Insufficiency | 2 | 2019 | 74 | 0.270 |
Why?
|
| Heart Arrest, Induced | 2 | 1996 | 12 | 0.250 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2025 | 40 | 0.240 |
Why?
|
| Delphi Technique | 2 | 2024 | 77 | 0.230 |
Why?
|
| Mineralocorticoid Receptor Antagonists | 1 | 2024 | 12 | 0.230 |
Why?
|
| Sternum | 2 | 2023 | 27 | 0.230 |
Why?
|
| Female | 14 | 2024 | 30705 | 0.230 |
Why?
|
| Postoperative Hemorrhage | 1 | 2024 | 37 | 0.230 |
Why?
|
| Hypoxia | 2 | 1995 | 112 | 0.230 |
Why?
|
| Selenium | 1 | 2024 | 25 | 0.220 |
Why?
|
| Adult | 12 | 2023 | 15669 | 0.220 |
Why?
|
| Radial Artery | 1 | 2004 | 49 | 0.220 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2024 | 147 | 0.210 |
Why?
|
| Attitude of Health Personnel | 3 | 2018 | 550 | 0.210 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 2337 | 0.210 |
Why?
|
| Standard of Care | 1 | 2023 | 27 | 0.210 |
Why?
|
| Postoperative Care | 2 | 2020 | 114 | 0.210 |
Why?
|
| Virulence | 2 | 2020 | 188 | 0.210 |
Why?
|
| Wounds, Nonpenetrating | 2 | 2003 | 103 | 0.210 |
Why?
|
| Pain Management | 2 | 2022 | 146 | 0.200 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2024 | 164 | 0.200 |
Why?
|
| Stroke Volume | 1 | 2024 | 314 | 0.200 |
Why?
|
| Databases, Factual | 2 | 2023 | 813 | 0.200 |
Why?
|
| Preoperative Care | 2 | 2020 | 180 | 0.200 |
Why?
|
| Drainage | 1 | 2023 | 149 | 0.200 |
Why?
|
| Penicillin G Benzathine | 1 | 2021 | 2 | 0.190 |
Why?
|
| Nutritional Status | 2 | 2019 | 93 | 0.190 |
Why?
|
| Arginine | 4 | 1996 | 110 | 0.190 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2021 | 49 | 0.190 |
Why?
|
| Occupational Health | 2 | 2020 | 181 | 0.190 |
Why?
|
| Aortic Valve | 1 | 2023 | 173 | 0.190 |
Why?
|
| Quality Indicators, Health Care | 1 | 2024 | 332 | 0.180 |
Why?
|
| Heart Valve Prosthesis Implantation | 2 | 2023 | 153 | 0.180 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2021 | 32 | 0.180 |
Why?
|
| Creatinine | 1 | 2021 | 128 | 0.180 |
Why?
|
| Pain, Postoperative | 1 | 2022 | 141 | 0.180 |
Why?
|
| China | 1 | 2021 | 134 | 0.180 |
Why?
|
| Europe | 1 | 2021 | 184 | 0.180 |
Why?
|
| Middle Aged | 7 | 2024 | 16317 | 0.170 |
Why?
|
| Patient Safety | 2 | 2020 | 237 | 0.170 |
Why?
|
| Sarcopenia | 1 | 2020 | 18 | 0.170 |
Why?
|
| Malnutrition | 1 | 2020 | 40 | 0.170 |
Why?
|
| Aorta, Thoracic | 1 | 2000 | 81 | 0.170 |
Why?
|
| Serum Albumin | 1 | 1999 | 45 | 0.160 |
Why?
|
| Organizational Innovation | 1 | 2020 | 81 | 0.160 |
Why?
|
| Myocardial Stunning | 2 | 1996 | 6 | 0.160 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2022 | 236 | 0.160 |
Why?
|
| Organ Preservation | 2 | 1996 | 19 | 0.160 |
Why?
|
| Medical Staff, Hospital | 1 | 2019 | 57 | 0.160 |
Why?
|
| Myocardium | 3 | 1995 | 264 | 0.160 |
Why?
|
| Anticoagulants | 1 | 2023 | 477 | 0.160 |
Why?
|
| Incidence | 3 | 2020 | 1237 | 0.160 |
Why?
|
| Mandatory Reporting | 1 | 2018 | 18 | 0.160 |
Why?
|
| Staphylococcus aureus | 1 | 2020 | 169 | 0.160 |
Why?
|
| Vaccination | 1 | 2021 | 334 | 0.150 |
Why?
|
| Resuscitation | 1 | 2019 | 69 | 0.150 |
Why?
|
| Consensus Development Conferences as Topic | 1 | 2018 | 13 | 0.150 |
Why?
|
| Child, Preschool | 3 | 2021 | 1782 | 0.150 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2018 | 46 | 0.150 |
Why?
|
| Cooperative Behavior | 1 | 2020 | 210 | 0.150 |
Why?
|
| Patient Handoff | 1 | 2018 | 35 | 0.150 |
Why?
|
| Myocardial Ischemia | 2 | 1996 | 111 | 0.150 |
Why?
|
| Prognosis | 2 | 2018 | 1600 | 0.150 |
Why?
|
| Surveys and Questionnaires | 2 | 2023 | 2513 | 0.150 |
Why?
|
| Ischemic Attack, Transient | 1 | 1999 | 90 | 0.150 |
Why?
|
| Budgets | 1 | 2017 | 7 | 0.150 |
Why?
|
| Disease Outbreaks | 1 | 2018 | 102 | 0.140 |
Why?
|
| Multiple Organ Failure | 1 | 2018 | 43 | 0.140 |
Why?
|
| Cost Savings | 1 | 2017 | 52 | 0.140 |
Why?
|
| Fee Schedules | 1 | 2017 | 2 | 0.140 |
Why?
|
| Renal Dialysis | 1 | 2018 | 189 | 0.140 |
Why?
|
| Reimbursement, Incentive | 1 | 2017 | 28 | 0.140 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2017 | 42 | 0.140 |
Why?
|
| Politics | 1 | 2017 | 32 | 0.130 |
Why?
|
| Patient Care Planning | 1 | 2017 | 84 | 0.130 |
Why?
|
| Fiji | 1 | 2016 | 2 | 0.130 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2022 | 687 | 0.130 |
Why?
|
| Cost-Benefit Analysis | 1 | 2017 | 297 | 0.130 |
Why?
|
| Endovascular Procedures | 1 | 2022 | 608 | 0.130 |
Why?
|
| Body Mass Index | 1 | 1999 | 831 | 0.130 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2016 | 42 | 0.130 |
Why?
|
| Anti-Bacterial Agents | 1 | 2021 | 735 | 0.130 |
Why?
|
| Myocardial Reperfusion | 1 | 1995 | 24 | 0.120 |
Why?
|
| Vascular Surgical Procedures | 1 | 2018 | 251 | 0.120 |
Why?
|
| Reference Values | 1 | 2016 | 326 | 0.120 |
Why?
|
| Rats, Sprague-Dawley | 5 | 1996 | 574 | 0.120 |
Why?
|
| Child | 3 | 2021 | 4174 | 0.110 |
Why?
|
| Computer Systems | 1 | 2013 | 14 | 0.110 |
Why?
|
| Cardiovascular Diseases | 1 | 2021 | 788 | 0.110 |
Why?
|
| Computer Graphics | 1 | 2013 | 19 | 0.110 |
Why?
|
| Global Health | 1 | 2015 | 167 | 0.110 |
Why?
|
| Adolescent | 4 | 2021 | 5824 | 0.110 |
Why?
|
| Quality Improvement | 1 | 2018 | 416 | 0.110 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 1093 | 0.110 |
Why?
|
| User-Computer Interface | 1 | 2013 | 123 | 0.100 |
Why?
|
| Lung | 1 | 2018 | 919 | 0.100 |
Why?
|
| Rats | 5 | 1996 | 1910 | 0.100 |
Why?
|
| Patient Readmission | 1 | 2017 | 420 | 0.100 |
Why?
|
| Monitoring, Physiologic | 1 | 2013 | 149 | 0.100 |
Why?
|
| Comprehension | 1 | 2013 | 131 | 0.100 |
Why?
|
| Logistic Models | 3 | 2020 | 1232 | 0.100 |
Why?
|
| Decision Support Techniques | 1 | 2013 | 179 | 0.100 |
Why?
|
| Double-Blind Method | 2 | 2024 | 715 | 0.090 |
Why?
|
| Kidney | 2 | 2023 | 416 | 0.090 |
Why?
|
| Heart Valve Diseases | 2 | 2023 | 88 | 0.090 |
Why?
|
| Aorta | 2 | 2022 | 108 | 0.080 |
Why?
|
| L-Lactate Dehydrogenase | 2 | 1996 | 31 | 0.060 |
Why?
|
| Coronary Circulation | 2 | 1996 | 50 | 0.060 |
Why?
|
| Oxidative Stress | 2 | 2024 | 279 | 0.060 |
Why?
|
| Sampling Studies | 1 | 2004 | 65 | 0.060 |
Why?
|
| Hospital Mortality | 2 | 2019 | 841 | 0.060 |
Why?
|
| Anastomosis, Surgical | 1 | 2004 | 107 | 0.050 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2023 | 23 | 0.050 |
Why?
|
| Graft Survival | 1 | 2004 | 290 | 0.050 |
Why?
|
| Brachiocephalic Trunk | 1 | 2003 | 15 | 0.050 |
Why?
|
| Wound Healing | 1 | 2004 | 174 | 0.050 |
Why?
|
| Accidents, Traffic | 2 | 2003 | 148 | 0.050 |
Why?
|
| Animals | 7 | 2000 | 19651 | 0.050 |
Why?
|
| Warfarin | 1 | 2023 | 105 | 0.050 |
Why?
|
| Antioxidants | 1 | 2024 | 241 | 0.050 |
Why?
|
| Dietary Supplements | 1 | 2024 | 223 | 0.050 |
Why?
|
| Intention to Treat Analysis | 1 | 2021 | 18 | 0.050 |
Why?
|
| Uganda | 1 | 2021 | 33 | 0.050 |
Why?
|
| Canada | 1 | 2022 | 147 | 0.050 |
Why?
|
| Belgium | 1 | 2021 | 6 | 0.050 |
Why?
|
| Netherlands | 1 | 2021 | 22 | 0.050 |
Why?
|
| Injections, Intramuscular | 1 | 2021 | 67 | 0.050 |
Why?
|
| Swine | 3 | 2000 | 352 | 0.050 |
Why?
|
| Decontamination | 1 | 2021 | 11 | 0.050 |
Why?
|
| Ischemic Preconditioning, Myocardial | 1 | 2000 | 22 | 0.040 |
Why?
|
| Renal Replacement Therapy | 1 | 2020 | 22 | 0.040 |
Why?
|
| Lipid A | 1 | 2000 | 66 | 0.040 |
Why?
|
| Perception | 1 | 2021 | 167 | 0.040 |
Why?
|
| Thoracotomy | 1 | 2000 | 44 | 0.040 |
Why?
|
| Nitric Oxide Synthase | 2 | 2000 | 45 | 0.040 |
Why?
|
| Cyclic GMP | 2 | 1996 | 28 | 0.040 |
Why?
|
| Hematoma | 1 | 2000 | 68 | 0.040 |
Why?
|
| Myocardial Contraction | 2 | 1996 | 85 | 0.040 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-2 | 1 | 2019 | 5 | 0.040 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 2019 | 7 | 0.040 |
Why?
|
| Chest Pain | 1 | 2000 | 81 | 0.040 |
Why?
|
| Morbidity | 1 | 1999 | 112 | 0.040 |
Why?
|
| Lipid Peroxidation | 2 | 1996 | 63 | 0.040 |
Why?
|
| Australia | 1 | 2019 | 86 | 0.040 |
Why?
|
| Diet, Carbohydrate Loading | 1 | 2018 | 2 | 0.040 |
Why?
|
| Nursing Staff, Hospital | 1 | 2019 | 65 | 0.040 |
Why?
|
| Databases as Topic | 1 | 2018 | 52 | 0.040 |
Why?
|
| Echocardiography | 1 | 2021 | 457 | 0.040 |
Why?
|
| Health Care Surveys | 1 | 2019 | 271 | 0.040 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2019 | 107 | 0.040 |
Why?
|
| Cause of Death | 1 | 2019 | 210 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2019 | 396 | 0.040 |
Why?
|
| Comorbidity | 1 | 2021 | 1078 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2019 | 555 | 0.040 |
Why?
|
| Patient Transfer | 1 | 2018 | 90 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2019 | 674 | 0.040 |
Why?
|
| Continuity of Patient Care | 1 | 2018 | 170 | 0.030 |
Why?
|
| Disease Progression | 1 | 2021 | 1122 | 0.030 |
Why?
|
| Occupational Exposure | 1 | 2020 | 307 | 0.030 |
Why?
|
| Hypoglycemic Agents | 1 | 2018 | 192 | 0.030 |
Why?
|
| Carbon Monoxide | 1 | 1996 | 61 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2018 | 470 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2003 | 1526 | 0.030 |
Why?
|
| Sex Factors | 1 | 2019 | 935 | 0.030 |
Why?
|
| Catalase | 1 | 1995 | 23 | 0.030 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 1995 | 10 | 0.030 |
Why?
|
| Electrolytes | 1 | 1995 | 25 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2018 | 412 | 0.030 |
Why?
|
| Cell Adhesion Molecules | 1 | 1995 | 85 | 0.030 |
Why?
|
| Infusions, Intravenous | 1 | 1995 | 164 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 1995 | 89 | 0.030 |
Why?
|
| Adenine Nucleotides | 1 | 1995 | 4 | 0.030 |
Why?
|
| Phosphocreatine | 1 | 1995 | 24 | 0.030 |
Why?
|
| Age Factors | 1 | 2019 | 1504 | 0.030 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 1995 | 78 | 0.030 |
Why?
|
| Insulin | 1 | 2018 | 674 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 1995 | 169 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 1995 | 471 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 1479 | 0.030 |
Why?
|
| Heart Rate | 1 | 1995 | 307 | 0.030 |
Why?
|
| Ventricular Function, Left | 1 | 1995 | 257 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2023 | 5128 | 0.030 |
Why?
|
| Quality of Life | 1 | 2020 | 1137 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2019 | 2374 | 0.030 |
Why?
|
| Blood Pressure | 1 | 1995 | 495 | 0.030 |
Why?
|
| Massachusetts | 1 | 2018 | 2002 | 0.030 |
Why?
|
| Obesity | 1 | 1999 | 1166 | 0.020 |
Why?
|
| Inflammation | 1 | 1995 | 1099 | 0.020 |
Why?
|
| Compartment Syndromes | 1 | 2003 | 10 | 0.010 |
Why?
|
| Aortography | 1 | 2003 | 55 | 0.010 |
Why?
|
| Enzyme Induction | 1 | 2000 | 44 | 0.010 |
Why?
|
| Guanidines | 1 | 2000 | 14 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2000 | 70 | 0.010 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2003 | 297 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2000 | 349 | 0.010 |
Why?
|
| Heme Oxygenase (Decyclizing) | 1 | 1996 | 8 | 0.010 |
Why?
|
| Bilirubin | 1 | 1996 | 17 | 0.010 |
Why?
|
| Free Radical Scavengers | 1 | 1996 | 18 | 0.010 |
Why?
|
| Temperature | 1 | 1996 | 295 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2000 | 1465 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 2000 | 862 | 0.010 |
Why?
|